Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Pimblett Emily | CHIEF ACCOUNTING OFFICER | 8 | $0 | $18.7K | 2024-09-20 |
| Kaplan Brett | Chief Operating Officer | 2 | $0 | $0 | 2024-08-26 |
| Morisset Valerie | EVP, R&D and CSO | 28 | $0 | $3.45M | 2024-07-22 |
| Thomas Stephen Basil | Director | 2 | $0 | $0 | 2024-06-27 |
| Brennan Aoife | President and CEO | 2 | $0 | $0 | 2024-06-27 |
| Kolchinsky Peter | Director, 10% Owner | 7 | $49.95M | $0 | 2024-06-27 |
| Levin Andrew David | Executive Chairman | 4 | $0 | $0 | 2024-06-26 |
| Tate Simon | Director | 4 | $0 | $0 | 2024-06-26 |
| Rosenberg Adam Joseph | Director | 4 | $0 | $0 | 2024-06-26 |
| Dunn Judith | Director | 3 | $0 | $0 | 2024-06-26 |
| Ratcliffe Liam | Director | 4 | $0 | $0 | 2024-06-26 |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 1 | $0 | $0 | 2023-05-18 |
| Lavelle Erin | COO & CFO | 2 | $0 | $0 | 2022-10-31 |
| Bucher James B | EVP and General Counsel | 2 | $0 | $0 | 2022-10-31 |
| Azelby Robert | President & CEO | 2 | $0 | $0 | 2022-10-31 |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | 15 | $40.00M | $0 | 2022-05-19 |
| PATTERSON LEONE D | Director | 1 | $0 | $0 | 2022-05-19 |
| Access Industries Holdings LLC | Other | 4 | $10.00M | $0 | 2021-08-12 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Pimblett Emily | CHIEF ACCOUNTING OFFICER | S Sale | 2024-09-20 | 2024-09-20 | 1,182 | $8.18 | $9.7K | 7,573 | SEC↗ |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER | S Sale | 2024-09-20 | 2024-09-20 | 9 | $8.06 | $73 | 7,564 | SEC↗ |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2024-09-18 | 2024-09-20 | 5,000 | — | $0 | 30,000 | SEC↗ |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER | M Exercise | 2024-09-18 | 2024-09-20 | 5,000 | — | $0 | 8,755 | SEC↗ |
| Kaplan Brett | Chief Operating Officer | A Award deriv | 2024-08-26 | 2024-08-26 | 77,500 | — | $0 | 77,500 | SEC↗ |
| Kaplan Brett | Chief Operating Officer | A Award deriv | 2024-08-26 | 2024-08-26 | 465,000 | — | $0 | 465,000 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-22 | 2024-07-23 | 30,000 | $7.98 | $239.4K | 31,317 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-22 | 2024-07-23 | 39,005 | $8.07 | $314.8K | 61,317 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-19 | 2024-07-23 | 10,201 | $7.09 | $72.3K | 150,322 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-19 | 2024-07-23 | 50,000 | $7.24 | $362.0K | 100,322 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-18 | 2024-07-19 | 38,576 | $6.93 | $267.3K | 160,523 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-17 | 2024-07-19 | 3,207 | $6.91 | $22.2K | 199,099 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-16 | 2024-07-17 | 50,000 | $7.13 | $356.5K | 202,306 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-15 | 2024-07-16 | 42,377 | $7.01 | $297.1K | 252,306 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-12 | 2024-07-16 | 50,000 | $7.07 | $353.5K | 294,683 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-11 | 2024-07-11 | 50,000 | $7.11 | $355.5K | 344,683 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-10 | 2024-07-11 | 50,000 | $6.83 | $341.5K | 394,683 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-09 | 2024-07-11 | 5,931 | $6.66 | $39.5K | 444,683 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-05 | 2024-07-09 | 12,342 | $7.06 | $87.1K | 450,614 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | S Sale | 2024-07-03 | 2024-07-03 | 50,000 | $6.76 | $338.0K | 462,956 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | M Exercise deriv | 2024-07-01 | 2024-07-03 | 7,649 | — | $0 | 10,198 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | M Exercise | 2024-07-01 | 2024-07-03 | 7,649 | — | $0 | 512,956 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | P Buy | 2024-06-27 | 2024-07-01 | 1,059,375 | $3.84 | $4.07M | 2,866,375 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | P Buy | 2024-06-27 | 2024-07-01 | 11,949,171 | $3.84 | $45.88M | 23,521,757 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award | 2024-06-27 | 2024-07-01 | 973,000 | — | $0 | 11,572,586 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award | 2024-06-27 | 2024-07-01 | 1,807,000 | — | $0 | 1,807,000 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award | 2024-06-27 | 2024-07-01 | 2,479,872 | — | $0 | 2,479,872 | SEC↗ |
| Thomas Stephen Basil | Director | A Award deriv | 2024-06-27 | 2024-06-27 | 100,375 | — | $0 | 100,375 | SEC↗ |
| Brennan Aoife | President and CEO | A Award deriv | 2024-06-27 | 2024-06-27 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Brennan Aoife | President and CEO | A Award deriv | 2024-06-27 | 2024-06-27 | 550,000 | — | $0 | 550,000 | SEC↗ |
| Thomas Stephen Basil | Director | A Award | 2024-06-27 | 2024-06-27 | 103,907 | — | $0 | 103,907 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2024-06-26 | 2024-06-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Tate Simon | Director | A Award deriv | 2024-06-26 | 2024-06-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Dunn Judith | Director | A Award deriv | 2024-06-26 | 2024-06-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Rosenberg Adam Joseph | Director | A Award deriv | 2024-06-26 | 2024-06-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Levin Andrew David | Executive Chairman | A Award deriv | 2024-06-26 | 2024-06-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2024-06-26 | 2024-06-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER | S Sale | 2024-06-20 | 2024-06-21 | 1,245 | $7.21 | $9.0K | 3,755 | SEC↗ |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2024-06-18 | 2024-06-21 | 5,000 | — | $0 | 35,000 | SEC↗ |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER | M Exercise | 2024-06-18 | 2024-06-21 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | M Exercise deriv | 2024-04-05 | 2024-04-08 | 17,847 | — | $0 | 28,046 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | M Exercise | 2024-04-05 | 2024-04-08 | 17,847 | — | $0 | 505,307 | SEC↗ |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER | M Exercise deriv | 2024-03-18 | 2024-03-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | M Exercise deriv | 2023-09-20 | 2024-03-04 | 15,297 | — | $0 | 45,893 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | M Exercise deriv | 2023-09-20 | 2024-03-04 | 5,431 | — | $0 | 0 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | M Exercise | 2023-09-20 | 2024-03-04 | 5,431 | — | $0 | 472,163 | SEC↗ |
| Morisset Valerie | EVP, R&D AND CSO | M Exercise | 2023-09-20 | 2024-03-04 | 15,297 | — | $0 | 487,460 | SEC↗ |
| Levin Andrew David | Executive Chairman | A Award deriv | 2023-05-18 | 2023-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Rosenberg Adam Joseph | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Dunn Judith | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Tate Simon | Director | A Award deriv | 2023-05-18 | 2023-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | A Award deriv | 2023-05-18 | 2023-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Morisset Valerie | EVP, R&D and CSO | M Exercise deriv | 2023-03-10 | 2023-03-14 | 61,191 | — | $0 | 61,190 | SEC↗ |
| Morisset Valerie | EVP, R&D and CSO | M Exercise deriv | 2023-03-10 | 2023-03-14 | 255,219 | — | $0 | 5,431 | SEC↗ |
| Morisset Valerie | EVP, R&D and CSO | M Exercise | 2023-03-10 | 2023-03-14 | 61,191 | — | $0 | 466,732 | SEC↗ |
| Morisset Valerie | EVP, R&D and CSO | M Exercise | 2023-03-10 | 2023-03-14 | 255,219 | — | $0 | 405,541 | SEC↗ |
| Bucher James B | EVP and General Counsel | A Award deriv | 2022-10-31 | 2022-11-02 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Lavelle Erin | COO & CFO | A Award deriv | 2022-10-31 | 2022-11-02 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Azelby Robert | President & CEO | A Award deriv | 2022-10-31 | 2022-11-02 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Morisset Valerie | EVP, R&D and CSO | A Award deriv | 2022-10-31 | 2022-11-02 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Dunn Judith | Director | A Award deriv | 2022-05-19 | 2022-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Levin Andrew David | Director | A Award deriv | 2022-05-19 | 2022-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Rosenberg Adam Joseph | Director | A Award deriv | 2022-05-19 | 2022-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PATTERSON LEONE D | Director | A Award deriv | 2022-05-19 | 2022-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2022-05-19 | 2022-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | A Award deriv | 2022-05-19 | 2022-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Tate Simon | Director | A Award deriv | 2022-05-19 | 2022-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Bucher James B | EVP and General Counsel | A Award deriv | 2022-01-27 | 2022-01-31 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Morisset Valerie | EVP, R&D and CSO | A Award deriv | 2022-01-27 | 2022-01-31 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Azelby Robert | President & CEO | A Award deriv | 2022-01-27 | 2022-01-31 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Lavelle Erin | COO & CFO | A Award deriv | 2022-01-27 | 2022-01-31 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Access Industries Holdings LLC | Other | C Conversion deriv | 2021-08-12 | 2021-08-16 | 3,568,375 | — | $0 | 0 | SEC↗ |
| Access Industries Holdings LLC | Other | C Conversion deriv | 2021-08-12 | 2021-08-16 | 641,025 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion deriv | 2021-08-12 | 2021-08-16 | 708,333 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion deriv | 2021-08-12 | 2021-08-16 | 673,076 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion deriv | 2021-08-12 | 2021-08-16 | 1,415,002 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion deriv | 2021-08-12 | 2021-08-16 | 2,639,507 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion deriv | 2021-08-12 | 2021-08-16 | 139,481 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion deriv | 2021-08-12 | 2021-08-16 | 485,493 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion deriv | 2021-08-12 | 2021-08-16 | 288,461 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion deriv | 2021-08-12 | 2021-08-16 | 518,164 | — | $0 | 0 | SEC↗ |
| Access Industries Holdings LLC | Other | C Conversion | 2021-08-12 | 2021-08-16 | 4,209,400 | — | $0 | 4,209,400 | SEC↗ |
| Access Industries Holdings LLC | Other | P Buy | 2021-08-12 | 2021-08-16 | 800,000 | $12.50 | $10.00M | 5,009,400 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion | 2021-08-12 | 2021-08-16 | 288,461 | — | $0 | 288,461 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion | 2021-08-12 | 2021-08-16 | 4,727,585 | — | $0 | 7,594,804 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion | 2021-08-12 | 2021-08-16 | 624,974 | — | $0 | 841,087 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | P Buy | 2021-08-12 | 2021-08-16 | 195,218 | $12.50 | $2.44M | 483,679 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | C Conversion | 2021-08-12 | 2021-08-16 | 1,226,497 | — | $0 | 1,226,497 | SEC↗ |
| RA Capital Nexus Fund II, L.P. | Director, 10% Owner | P Buy | 2021-08-12 | 2021-08-16 | 3,004,782 | $12.50 | $37.56M | 10,599,586 | SEC↗ |
| Levin Andrew David | Director | A Award deriv | 2021-08-09 | 2021-08-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Tate Simon | Director | A Award deriv | 2021-08-09 | 2021-08-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Rosenberg Adam Joseph | Director | A Award deriv | 2021-08-09 | 2021-08-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2021-08-09 | 2021-08-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2021-08-09 | 2021-08-11 | 20,000 | — | $0 | 20,000 | SEC↗ |